- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02860026
Growth and Tolerance of Healthy Term Infants Fed Cow's Milk-Based Infant Formulas
May 26, 2017 updated by: Mead Johnson Nutrition
This clinical trial will compare the growth and tolerance of infants who consume an investigational cow's milk-based infant formula to those who consume a marketed cow's milk-based infant formula through approximately 4 months of age.
Study Overview
Status
Withdrawn
Conditions
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35205
- Birmingham Pediatric Associates
-
Dothan, Alabama, United States, 36305
- Southeastern Pediatric Associates
-
-
Arkansas
-
Fayetteville, Arkansas, United States, 72703
- Northwest Arkansas Pediatric Clinic
-
Jonesboro, Arkansas, United States, 72401
- The Children's Clinic of Jonesboro, P.A.
-
-
Connecticut
-
Norwich, Connecticut, United States, 06360
- Norwich Pediatric Group, P.C.
-
-
Florida
-
Lake Mary, Florida, United States, 32746
- Altamonte Pediatric Associates
-
-
Indiana
-
Evansville, Indiana, United States, 47725
- Deaconess Clinical Research
-
-
Kentucky
-
Bardstown, Kentucky, United States, 40004
- Kentucky Pediatrics/Adult Research
-
Owensboro, Kentucky, United States, 42303
- Owensboro Pediatrics
-
-
Ohio
-
Cincinnati, Ohio, United States, 45245
- Pediatric Associates of Mt. Carmel, Inc.
-
Dayton, Ohio, United States, 45414
- Ohio Pediatric Research Association
-
Fairfield, Ohio, United States, 45014
- Pediatric Associates of Fairfield, Inc.
-
Westlake, Ohio, United States, 44145
- UHMP Comprehensive Pediatrics
-
-
South Carolina
-
Charleston, South Carolina, United States, 29414
- Coastal Pediatric Research
-
-
Tennessee
-
Jackson, Tennessee, United States, 38305
- The Jackson Clinic - North Jackson
-
Kingsport, Tennessee, United States, 37660
- Holston Medical Group
-
-
Texas
-
Longview, Texas, United States, 75605
- DCOL Center for Clinical Research
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 week to 2 weeks (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Singleton 10-14 days of age at randomization
- Term infant with birth weight of minimum of 2500 grams
- Solely formula fed
- Signed informed consent and protected health information
Exclusion Criteria:
- History of underlying metabolic or chronic disease, anemia, or immune compromise
- Feeding difficulties or formula intolerance
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control
Marketed cow's milk-based infant formula
|
|
|
Experimental: Investigational
Cow's milk-based infant formula with added nutrients
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Rate of body weight gain from 14 to 120 days of age
Time Frame: 3.5 months
|
3.5 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Recall of infant formula at each study visit
Time Frame: Up to 3.5 months
|
Up to 3.5 months
|
|
Body length measured at each study visit
Time Frame: Up to 3.5 months
|
Up to 3.5 months
|
|
Recall of stool characteristics questionnaire measured at each study visit
Time Frame: Up to 3.5 months
|
Up to 3.5 months
|
|
Head circumference measured at each study visit
Time Frame: Up to 3.5 months
|
Up to 3.5 months
|
|
Recall of gastrointestinal tolerance questionnaire at each study visit
Time Frame: Up to 3.5 months
|
Up to 3.5 months
|
|
Medically confirmed adverse events collected throughout the study period
Time Frame: Up to 3.5 months
|
Up to 3.5 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2016
Primary Completion (Anticipated)
March 1, 2018
Study Completion (Anticipated)
April 1, 2018
Study Registration Dates
First Submitted
August 3, 2016
First Submitted That Met QC Criteria
August 4, 2016
First Posted (Estimate)
August 9, 2016
Study Record Updates
Last Update Posted (Actual)
May 31, 2017
Last Update Submitted That Met QC Criteria
May 26, 2017
Last Verified
May 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- 3388-1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Growth
-
University of California, DavisCompletedGrowth Acceleration | Growth RetardationUnited States
-
Northwell HealthRecruitingGrowth | Growth Disorders | Growth Failure | Growth Hormone TreatmentUnited States
-
Novo Nordisk A/SCompletedGrowth Hormone Disorder | Adult Growth Hormone DeficiencyFrance
-
Novo Nordisk A/SCompletedGrowth Hormone Disorder | Adult Growth Hormone DeficiencyDenmark
-
Novo Nordisk A/SCompletedGrowth Hormone Disorder | Adult Growth Hormone DeficiencyGermany
-
Novo Nordisk A/SCompletedGrowth Hormone Disorder | Growth Hormone Deficiency in ChildrenIsrael, Denmark, Belgium, Spain, Macedonia, The Former Yugoslav Republic of, Turkey, United Kingdom, France, Slovenia, Czech Republic
-
Novo Nordisk A/SWithdrawnGrowth Hormone Disorder | Growth Hormone Deficiency in Children
-
Novo Nordisk A/SCompletedHealthy | Growth Hormone Disorder | Adult Growth Hormone DeficiencyUnited States
-
University of CopenhagenUniversity of Aarhus; Arla FoodsCompletedGrowth Acceleration | Growth; Stunting, NutritionalDenmark
-
Novo Nordisk A/SCompletedGrowth Hormone Disorder | Growth Hormone Deficiency in Children | Delivery SystemsGermany, Netherlands, Sweden
Clinical Trials on Marketed cow's milk-based infant formula
-
Mead Johnson NutritionUniversity of Kansas Medical CenterCompletedBehavioral Measures of ToleranceUnited States
-
Ausnutria Hyproca B.V.Not yet recruitingInfections | Quality of Life | Gastrointestinal Tolerance | Gastrointestinal Symptoms | AnthropometricsSaudi Arabia
-
Ausnutria Hyproca B.V.Completed
-
Mead Johnson NutritionUniversity of North Carolina, Chapel HillTerminatedDeclarative MemoryUnited States
-
Mead Johnson NutritionCompletedCommon Infant Feeding ProblemsUnited States, Canada
-
Ausnutria Hyproca B.V.Active, not recruitingGrowth | Infection | Gastrointestinal Symptoms | Allergy SymptomsSaudi Arabia
-
Ausnutria Hyproca B.V.HM hospitalesCompleted
-
Mead Johnson NutritionFederal University of BahiaCompletedChild Nutrition SciencesBrazil
-
Medical University of WarsawAusnutria Hyproca B.V.Not yet recruitingGastrointestinal Diseases | Infant Nutrition DisordersPoland